Seed Round

American Uranium secures over 1,000 acres at its Lo Herma project, bolstering domestic uranium resources amid a global nuclear energy resurgence.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

Geviti Health has launched a first-of-its-kind free AI platform to analyze bloodwork, promising to make preventative health more accessible than ever.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

A luxury brand and an NGO award women in bio-tech and MedTech, tackling the stark funding gap and championing a new generation of impact-driven founders.

A first-in-class AI software, neuropacs™, gains FDA clearance, promising to help doctors differentiate complex Parkinsonian syndromes with high accuracy.

AI pioneer Adaptive ML hires a new CMO and CRO, signaling an aggressive push to turn its advanced Reinforcement Learning tech into commercial supremacy.

As Ontario hospitals face a financial crisis, a major innovation week aims to connect Canadian startups with global capital to solve healthcare's biggest challenges.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

A new company is selling franchises to doctors and pharmacists, promising to cut out insurers and restore local care. But can this bold model survive the system?

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

Brands are disappearing from new AI search engines. A new discipline called 'Machine Relations' aims to solve this 'AI invisibility' crisis.

Evaline Tsai's promotion at Gigascale Capital highlights a new VC playbook where deep scientific expertise is crucial for funding our physical economy's future.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

Ann Arbor startup Adrenaline Interactive lands a $1M prize to revolutionize in-game ads, signaling Michigan's push to become a tech innovation hub.

A small environmental firm unveils a plan to upend global markets with a fraud-proof 'Physical Truth Infrastructure.' But can it deliver on its promises?

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

As AlphaPepe prepares to launch its AI-powered crypto exchange amidst a bullish market, a closer look at its security audit reveals significant contradictions.